The Market Reports

Synopsis
The global market for Antifungal and Ringworm Treatment Drugs was estimated to be worth US$ 3542 million in 2024 and is forecast to a readjusted size of US$ 4705 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Fungal tinea drugs, also known as fungal drugs for lichen diseases, are drugs used to treat skin tinea diseases caused by fungal infections. Fungal infections usually cause symptoms such as erythema, desquamation, itching, and cracking on the skin. Common diseases include athlete's foot, tinea versicolor, tinea corporis, tinea cruris, and tinea manuum. Fungal infections may be caused by different types of fungi. Antifungal drugs can inhibit or kill these fungi and help treat and relieve symptoms. Currently, commonly used topical antifungal drugs in clinical practice can be divided into imidazoles, allylamines, and other antifungal drugs. Imidazole antifungal drugs include clotrimazole, econazole, miconazole, ketoconazole, etc. Allylamine antifungal drugs include naftifine, terbinafine, and butenafine. Other antifungal drugs include amorolfine, ciclopirox olamine, liranapthate, etc.
There are various types of fungal tinea drugs, including topical drugs and oral drugs. Topical drugs include antifungal creams, sprays, lotions, patches, etc., which are usually used for local treatment of fungal infections of the skin. Oral drugs are mainly used to treat extensive or stubborn fungal infections, such as itraconazole and fluconazole, which have strong systemic therapeutic effects. With the segmentation of treatment needs, some new drug forms, such as long-acting sprays and topical application formulations, have gradually gained market favor and met the treatment needs of different patients.
With the advancement of science and technology, the research and development of fungal tinea drugs around the world has gradually developed towards innovation and efficient treatment. The new generation of antifungal drugs can not only improve the treatment effect, but also optimize the side effects. For example, some new drugs can reduce the risk of liver damage and solve the problem of side effects that may be caused by traditional drugs during long-term use. In addition, the course of treatment and the way of use of drugs are also gradually improving. Many new drugs use more convenient dosage forms and shorter treatment cycles, which are more attractive in the market.
The global market demand for fungal tinea drugs varies in different regions. The markets in developed countries and regions are relatively mature, with higher drug prices and a higher degree of standardized treatment. In developing countries, however, due to the limitations of economic level and medical resources, low-priced generic drugs and basic treatment methods dominate the market. In these regions, despite the higher rates of fungal infections, the popularity and use of drugs are affected. Therefore, global pharmaceutical companies need to consider the differences in demand in different regions when making global layouts and adjust their pricing and market strategies.
This report aims to provide a comprehensive presentation of the global market for Antifungal and Ringworm Treatment Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antifungal and Ringworm Treatment Drugs by region & country, by Type, and by Application.
The Antifungal and Ringworm Treatment Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antifungal and Ringworm Treatment Drugs.
Market Segmentation
By Company
Johnson & Johnson
Bausch Health
Bayer
Kaken Pharmaceutical
Gufic Biosciences
Galderma
Perrigo
Padagis
GSK
Novartis
Shandong Jingwei Pharmaceutical
Jiangsu Zhiyuan Pharmaceutical
Sandoz
Ultratech India
Teva Pharmaceuticals
Hubei Hengan Fulin
Chengdu Beite Pharmaceuticals
Shanghai Modern Hasen (Shangqiu)
Tianjin Lisheng
Shandong Luoxin
Harbin Sanlian
Hainan Kangzhi
Guilin Huaxin
Shandong Qilu
Jiangsu Yunyang Group
Segment by Type
External Drug
Oral Drug
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antifungal and Ringworm Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antifungal and Ringworm Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antifungal and Ringworm Treatment Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index